Health Canada recently announced a highly favourable policy for small businesses in the pharmaceutical and medical device sectors: the validity period of small business status will be extended from 12 months to 24 months. This change not only directly reduces the administrative burden of repeated applications and renewals, but also enables eligible businesses to benefit more consistently over a longer period from substantive policy advantages such as a free first application and fee mitigation for subsequent applications.
The following detailed interpretation is based on the official communication and current regulations, and is provided for reference by businesses expanding overseas.
Core Change: Validity Period Doubled with Automatic Updates
According to an official communication issued by Health Canada, effective 21 October 2026, the validity period of all valid small business statuses will be formally extended from the previous 12 months to 24 months. This is an important measure by Health Canada to streamline regulatory processes and reduce the administrative burden on businesses.
Key details and operational reminders:
Automatic updates: Businesses do not need to take any action. For businesses that have already been certified, their status will be updated automatically. For example, small business status originally due to expire on 15 November 2026 will be automatically extended to 15 November 2027.
Delay in system display: Please note that, because system updates take time, the Secure Web Portal may continue to display a 12-month validity period in the short term. Health Canada has made it clear that this is solely a system display issue and that the actual back-end data is already calculated on a 24-month basis.
Renewal reminders: Although the validity period has been extended, Health Canada will still send a reminder before expiry. Businesses may submit a renewal application through the portal up to three months before the validity period expires.
The Substantive Benefit Behind the Extension: Ongoing Fee Mitigation
The extended validity period matters because maintaining small business status is a prerequisite for benefiting from Health Canada’s various fee mitigation measures. Under the Fees in Respect of Drugs and Medical Devices Order and related guidance, eligible businesses can receive the following core benefits:
First Application Free of Charge
For a small business submitting its first pre-market evaluation application to Health Canada, the applicable fee is waived (100% fee mitigation).
Half Price for All Other Applications
After eligibility for the first free application has been used, all pre-market evaluation fees are eligible for a 50% reduction.
Licence and Annual Fee Reductions
A 25% reduction is available for right to sell fees and establishment licence fees.
Eligibility criteria (affiliated companies must also be included):
- Fewer than 100 employees; or
- Annual gross revenue between CAD 30,000 and CAD 5 million.
Compliance Reminder: The Timing of Eligibility Assessment Is Critical
Although the extended validity period provides convenience, businesses must still pay attention to compliance details when claiming fee mitigation to avoid financial losses caused by procedural issues.
Obtain certification before submitting, and allow 48 hours: Eligibility for fee mitigation depends on whether the business holds valid small business status at the moment the application is submitted. If an application is submitted while the status has expired or has not yet been approved, the business may still be required to pay the full fee for that application even if its status is subsequently renewed successfully. Special reminder: After receiving confirmation of status, it is recommended to wait at least 48 hours before submitting an application to ensure that the system is fully synchronised.
Active declaration: After obtaining small business status, a business must still actively select and declare its small business status in the relevant fee form or regulatory transaction template each time it submits an application, to ensure that the system applies the discount correctly.
Information maintenance: If significant changes to the business structure, number of employees or revenue mean that the business no longer meets the definition of a small business, it must update its status promptly to avoid compliance risks arising from improperly receiving fee mitigation.
Conclusion
Health Canada’s decision to double the validity period of small business status provides substantive support for the pharmaceutical innovation ecosystem. For Chinese pharmaceutical and medical device companies planning to enter the North American market, making full use of this policy can not only effectively control compliance costs, but also allow more flexibility in planning product registration and commercialisation over a two-year period. Relevant businesses are advised to check their status information in the Secure Web Portal regularly and ensure that their eligibility remains valid before every critical submission.
This article has been prepared on the basis of Health Canada’s official communication and the Fees in Respect of Drugs and Medical Devices Order. It is provided solely for industry communication and reference and does not constitute legal or regulatory advice. Specific applicability is subject to the latest rules published by Health Canada.